At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NAOV NanoVibronix Inc
Post-Market Trading 11-05 18:21:52 EST
0.6226
+0.0536
+9.42%
盘后0.6226
+0.00000.00%
16:42 EST
High0.6226
Low0.5700
Vol121.27K
Open0.5700
D1 Closing0.5690
Amplitude9.24%
Mkt Cap2.34M
Tradable Cap2.32M
Total Shares3.75M
T/O72.20K
T/O Rate3.26%
Tradable Shares3.72M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
NanoVibronix Signs Term Sheet With Apogepha for Europe Distribution of UroShield Urology Therapy Device
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally. The company's product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements. The company was incorporated in 2003 and is headquartered in Tyler, Texas.